Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opana ER in Opioid-Naive Chronic Pain
NCT00911287Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Jun 2003
- Primary completion
- Jan 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of oxymorphone in chronic pain, sponsored by Endo International plc. Started Jun 2003; status: completed.
02
Drugs
oxymorphone
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT00911287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911287.